Zakir Ali

Dr. Zakir Ali


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Gels
Verified
Journal Article
Open access
PDF file
HRHassan Raza
Hassan Raza
SSShefaat Ullah Shah
Shefaat Ullah Shah
ZAZakir Ali
Zakir Ali
AKAtif Ullah Khan
Atif Ullah Khan
IRIrfa Basharat Rajput
Irfa Basharat Rajput
KSKifayat Ullah Shah
Kifayat Ullah Shah
Psoriasis is chronic autoimmune disease that affects 2–5% of the global population. Fluocinolone acetonide (FLU) and acitretin (ACT) are widely used antipsoriatic drugs that belong to BCS classes II and IV, respectively. FLU exhibits side effects, such as skin irritation and a burning sensation. ACT also shows adverse effects, such as gingivitis, teratogenic effects and xerophthalmia. In the present study, topical nanostructured lipid carriers (NLCs) were fabricated to reduce the side effects and enhance the therapeutic efficacy. FLU–ACT-coloaded NLCs were prepared by the modified microemulsion method and optimized by the Box–Behnken model of Design Expert® version 12. The optimization was based on the particle size (PS), zeta potential (ZP) and percentage of encapsulation efficiency (%EE). The physicochemical analyses were performed by TEM, FTIR, XRD and DSC to assess the morphology, chemical interactions between excipients, crystallinity and thermal behavior of the optimized FLU–ACT-coloaded NLCs. The FLU–ACT-coloaded NLCs were successfully loaded into gel and characterized appropriately. The dialysis bag method and Franz diffusion cells were used for the in vitro release and ex vivo permeation studies, respectively. The optimized FLU–ACT-coloaded NLCs had the desired particle size of 288.2 ± 2.3 nm, ZP of −34.2 ± 1.0 mV and %EE values of 81.6 ± 1.1% for ACT and 75 ± 1.3% for FLU. The TEM results confirmed the spherical morphology, while the FTIR results showed the absence of chemical interactions of any type among the ingredients of the FLU–ACT-coloaded NLCs. The XRD and DSC analyses confirmed the amorphous nature and thermal behavior. The in vitro study showed the sustained release of the FLU and ACT from the optimized FLU–ACT-coloaded NLCs and FLU–ACT-coloaded NLC gel compared with the FLU–ACT suspension and conventional gel. The ex vivo study confirmed the minimal permeation of both drugs from the FLU–ACT-coloaded NLC gel.

27 November 2022 in PHYTONutrients
Verified
Journal Article
Open access
PDF file
Yaseen HussainYaseen Hussain
Yaseen Hussain
Prof. Dr. Haroon KhanProf. Dr. Haroon Khan
Prof. Dr. Haroon Khan
WAWaqas Alam
Waqas Alam
ZAZakir Ali
Zakir Ali
MIMuhammad Ibrar
Muhammad Ibrar
DIABETES mellitus is a multifactorial chronic metabolic disorder characterized by altered metabolism of macro – nutrients such fats, proteins and carbohydrates associated with disturbances in insulin activity. Diabetes mellitus complications include, diabetic retinopathy, diabetic cardiomyopathy, diabetic encephalopathy, diabetic periodontitis and diabetic nephropathy. These complications are mostly induced by inflammatory and oxidative mediators. Curcumin is a polyphenol extracted from turmeric and it is well known for its antioxidant, anti-inflammatory and antiapoptotic activities. It effectively targets oxidative mediators in diabetes mellitus through regulation of several signaling pathways. Insulin resistance is commonly caused due to impairment in the signaling pathways related to insulin and the target tissues pose lesser or no response to circulating insulin. Curcumin is a potent therapeutic agent that targets oxidative stress mediators in diabetes mellitus and its resistant version leading to favorable therapeutic outcomes in diabetes complications. This review has thrown sufficient light on the therapeutic potential of curcumin targeting oxidative mediators in diabetes and its related complications.

28 November 2023 in PHYTONutrients
Verified
Journal Article
Open access
PDF file
MJMuhammad Junaid
Muhammad Junaid
ABAiny Butt
Ainy Butt
ZAZakir Ali
Zakir Ali
Yaseen HussainYaseen Hussain
Yaseen Hussain
GINSENOSIDES, the principal constituent of plants from genus Panax, have been indicated in multitudinous of ailments by the Homos sapiens, for more than 2 millennia. Mostly and notably the ginsenosides, the mainstay of Chinese herbal system of medication, are harnessed for multifarious disorders viz. Neurodegenerative diseases, Diabetes mellitus, Cardiovascular abnormalities, Septic shock, inflammatory disorders, Obesity and most striking of all owing to the prevalent circumstances have to potential to manage, even treat COVID-19, albeit empirically. Whereas, considering the plant itself, it strikes to the researcher as perennial although, with significantly slow progress. The spectrum of the review encompasses the functional reach of the ginsenosides with special emphasis on the antiplatelet therapeutics, in conjunction with the notoriety and the prospect of the compounds in multitude of disorders. However, the mechanism on which the edifice, of the antithrombotic efficiency is contingent, is expressed with keen interest. Ultimately, the root or its extract, is evidenced to be sufficiently effective in curbing the foresaid ailments whether authenticated by systematic review, clinical trials, mechanistic patterns and animal investigations. Overall, the herb shows immense potential to be packaged into a unit dosage form and be brought in the prevalent market especially as an antithrombotic agent.